Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs BMRN✓SelectedUSD · BMRNGSK vs BMRN performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs BMRN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+55.4%
BMRN return
-29.7%
Excess return
+85.0%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioBMRNExcessAlpha
1D-1.3%+5.0%-6.3%-2.3%
7D-3.1%+5.3%-8.4%-4.1%
30D-0.9%+12.4%-13.3%-3.1%
3M-4.2%-8.3%+4.1%-2.8%
6M-1.6%+23.7%-25.3%-5.6%
YTD+2.6%+3.4%-0.8%+1.4%
1Y+6.2%+13.4%-7.2%+3.0%
All+55.4%-29.7%+85.0%+57.0%

Cumulative growth

Daily Returns

Daily percentage return beside BMRN.

Daily Out/Under-Performance

Portfolio return minus BMRN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BMRN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded BMRN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling